Sleep Disorders

News of Note

Jornay PM Nighttime Stimulant for Next-Morning Effect

Topics: ADHD | News of Note | Sleep Disorders

Prescribing bedtime stimulants sounds like a recipe for a bad night’s sleep. But the FDA recently approved Jornay PM, which is an extended release (ER) formulation of methylphenidate that is, in fact, dosed at night. Approved for kids age 6 and older, Jornay PM has an extremely delayed onset of effect of 10 hours. This means kids can take it at aro

Read More
Article

Sleep Apnea in Patients With Substance Use Disorders: A Primer

Topics: Addiction | Sleep Disorders | Substance Abuse

A 55-year-old male patient you have been treating for alcohol use disorder has been struggling with withdrawal following detox. He tells you his spouse is complaining about his severe and disruptive snoring, and he says he feels “wiped out” all day, even falling asleep at work. He then admits that, to stay alert, he has been regularly taking Adderal

Read More
Expert Q&A

Treating Insomnia With Addiction

Topics: Addiction | Sleep Disorders | Substance Abuse

CATR: With substance use disorders (SUDs) that are comorbid with chronic insomnia, what would you say are some of the main treatment challenges? Dr. Hermes: The first thing I’d say is that chronic insomnia has a high comorbidity rate with SUDs as well as general psychiatric conditions and medical conditions, including chronic pain, COPD, heart diseas

Read More
Article

Non-Addictive, Pharmacological Options for Sleep

Topics: Addiction | Psychopharmacology Tips | Sleep Disorders | Substance Abuse

In this month’s interview with Dr. Eric Hermes, we learned about his approach to treating insomnia in patients with substance use disorders, with a focus on cognitive behavioral therapy. In this article, we’ll look at some non-addictive pharmacological options. That means we’re not going to review any of the benzodiazepines or the non-benzodiazepi

Read More
Expert Q&A

Cognitive Behavior Therapy for Insomnia

Topics: Practice Tools and Tips | Psychotherapy | Sleep Disorders

TCPR: Dr. Perlis, you are one of the major researchers of cognitive behavior therapy for insomnia. Why are you so interested in the topic of insomnia? Dr. Perlis: Because insomnia is so ubiquitous and misunderstood with respect to its health consequences and “treatability.” At the core of this is the widespread misconception that insomnia is prim

Read More
Article

Disrupted Sleep: Approaches to Assessment and Treatment in Children and Adolescents

Topics: Child Psychiatry | Sleep Disorders

Although sleep problems occur frequently in the pediatric population, with rates between 25%–40%, they too often go unrecognized and untreated (Sheldon S, Ferber R, Kryger M., Principles and Practice of Pediatric Sleep Medicine. Philadelphia, PA: Elsevier; 2005). In his Q&A interview in this issue, Dr. Rafael Pelayo nicely addresses how common sle

Read More
Article

Got Zeitgebers? You Should

Topics: Child Psychiatry | Sleep Disorders

There are many potential causes of poor sleep in children, but regardless of the cause, it is important to be aware of overarching environmental factors that can affect sleep. The German word zeitgeber (literally “time-giver”) refers to any cue in the environment such as a change in light or temperature that can set the body’s internal clock. To s

Read More
Expert Q&A

Poor Sleep in Children and Adolescents: A Primer

Topics: Child Psychiatry | Sleep Disorders

Read More
Article

A Narcolepsy Primer, With a Focus on Xyrem

Topics: Psychopharmacology Tips | Sleep Disorders

Narcolepsy affects about 1 out of 2000 people, for a prevalence rate of 0.05%. This puts it officially in the category of rare diseases. It’s about as common as Charcot-Marie-Tooth disease, or polycythemia vera, just to put it in perspective. So why are we asking you to read about such a rare disorder? Partly because there’s a lot of comorbidity bet

Read More
Expert Q&A

What Psychiatrists Should Know About Sleep Medicine

Topics: Benzodiazepines | Practice Tools and Tips | Psychopharmacology Tips | Sleep Disorders

Read More
Article

Belsomra: A New Hypnotic? Don’t Get Too Excited

Topics: Sleep Disorders

In the wake (pun intended) of last year’s FDA warnings of next-morning impairment and the lower dosing recommendations for “Z drugs,” wouldn’t now be the perfect time for a new hypnotic to enter the marketplace? Suvorexant, which will be marketed by Merck & Co. under the brand name Belsomra, was approved by the FDA in August 2014. It trul

Read More
News of Note

Another Sleeping Pill on the Market: Merck’s Belsomra

Topics: News of Note | Sleep Disorders

Read More

Treating Insomnia